« Back
Home /
Dotinurad (FYU-981)

Dotinurad (FYU-981)

Item no.	V20194-250mg
Manufacturer	InvivoChem LLC
CASRN	1285572-51-1
Amount	250 mg
Quantity options	100 mg 10 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V20194CAS #:1285572-51-1Purity >=98% Description: Dotinurad (FYU-981) is a novel, potent and selective urate reabsorption inhibitor (SURI) approved in Japan for treatment of hyperuricemia and gout. It has potent inhibitory effects at low doses on the uptake of urate by urate transporter 1 (URAT1) with an IC50 of 3.6 uM for uric acid. References: Eur J Med Chem. 2019 Mar 15; 166:186-196.; Drug Metab Pharmacokinet. 2020 Mar 9. pii: S1347-4367(20)30018-5.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 9/4/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer